Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung CancerLuis Paz‐Ares, Dariusz M. Kowalski, Mahmut Gümüş et al.|New England Journal of Medicine|2018Cited by 3.7k
Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem CellsNannan Zhou, Chengwei Zou, Jianchun Wang et al.|Cardiovascular Drugs and Therapy|2016Cited by 2